TNM

Zaragoza city puts 17 hybrid buses from Volvo into operation

Zaragoza city puts 17 hybrid buses from Volvo into operation

In a move marking the integration of hybrid buses in Zaragoza, the Spanish city has recently put 17 Volvo hybrid buses into service.

Peugeot announces prices for e-208 in the UK

Peugeot announces prices for e-208 in the UK

In an official announcement, Peugeot UK has finally revealed the cost and specifications of the upcoming, all-new 208 in the country. The automaker has also released details pertaining to the electric version of the 208 --- the e-208.

Retail Chain Wawa plans Tesla Superchargers at 30 stores within a year

Retail Chain Wawa plans Tesla Superchargers at 30 stores within a year

US electric vehicle manufacturer Tesla and convenience store chain Wawa are planning the expansion of Tesla Supercharger network at Wawa stores.

President Trump backs down on Higher Tariffs on Chinese Goods

President Trump backs down on Higher Tariffs on Chinese Goods

President Trump backed down on his tariffs increase on Chinese goods as the stock markets plunged. As the treasury yields turned negative, stock markets witnessed strong selling. Investors panicked and this led President Trump to have a conversation with banking leaders on the issue.

Hero MotoCorp plant to remain closed for four days due to lower demand

Hero MotoCorp plant to remain closed for four days due to lower demand

In another alarming sign for Indian automobile sector, Hero MotoCorp has announced that the company will keep its plant shut for four days on account of holidays and lower demand for its two-wheelers. Hero MotoCorp has been market leader in many two-wheeler segments and the company has witnessed strong growth in profit and sales over years.

Panacea Biotec reports lower loss at Rs 28 crore during first quarter

Panacea Biotec reports lower loss at Rs 28 crore during first quarter

Panacea Biotec has reported lower quarterly loss at Rs 28 crore compared to the same period last year. The company has managed to reduce its losses and increase its sales revenue to Rs 125 crore compared to Rs 99 crore for the same period last year.

The company also informed that it has received United States Food and Drug Administration (USFDA) approval for Oncology Parenteral Formulations.

Talking about the results, Panacea Biotec MD Rajesh Jain said, "The company's remediation measures have now started paying off. The company has registered impressive financial performance during the quarter ended June 30, 2019 with 28 per cent topline growth and earning positive earnings before interest, taxes, depreciation and amortization (EBITDA) of Rs 26.9 crore."

Pages